Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Exploring D2 receptor isoforms with [11C]-(+)-PHNO Radiotracer
FY 2016-17
Summary
The underlying impairment of motor planning and action selection in Parkinson’s disease (PD) stems from the dopaminergic neuron loss within the striatum and prefrontal cortex. These neurons contain two dopamine D2 receptor isoforms — D2 long (D2L) and D2 short (D2S). The single nucleotide polymorphisms within the gene for these isoforms, DRD2, may have a significant impact on receptor function by controlling the expression of the D2L and D2S receptors. The differential role of D2L and D2S are not fully understood, but they seem to have distinct contributions to dopamine signalling in the striatum. Recent developments of new biomarkers in positron emission tomography (PET) that can be used in humans are allowing us to fill in the knowledge gap. A novel high-affinity radiotracer biomarker — [11C]-(+)-PHNO (PHNO) — has promising properties that allow high sensitivity and specificity in detecting D2 receptors. In this pilot study, our aim is to test whether PHNO is able to display different imaging patterns associated with D2L and D2S isoforms in the nigrostriatal dopaminergic systems of healthy young individuals. This pilot study has the potential to elucidate the specific mechanisms through which these DRD2 variants operate in modulating the function of the nigrostriatal dopaminergic system. The findings from this pilot study will set a critical foundation for near-future studies using PHNO to better understand the pathophysiology of PD patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
368979
Name
Valli Mikaeel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring D2 receptor isoforms with [11C]-(+)-PHNO Radiotracer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Dopamine D2 Receptors; Drd2 Gene; Nigrostriatal Dopaminergic System; Positron Emission Tomography; Single Nucleotide Polymorphism; [11c]-(+)-Phno Radiotracer
Abstract
The underlying impairment of motor planning and action selection in Parkinson’s disease (PD) stems from the dopaminergic neuron loss within the striatum and prefrontal cortex. These neurons contain two dopamine D2 receptor isoforms — D2 long (D2L) and D2 short (D2S). The single nucleotide polymorphisms within the gene for these isoforms, DRD2, may have a significant impact on receptor function by controlling the expression of the D2L and D2S receptors. The differential role of D2L and D2S are not fully understood, but they seem to have distinct contributions to dopamine signalling in the striatum. Recent developments of new biomarkers in positron emission tomography (PET) that can be used in humans are allowing us to fill in the knowledge gap. A novel high-affinity radiotracer biomarker — [11C]-(+)-PHNO (PHNO) — has promising properties that allow high sensitivity and specificity in detecting D2 receptors. In this pilot study, our aim is to test whether PHNO is able to display different imaging patterns associated with D2L and D2S isoforms in the nigrostriatal dopaminergic systems of healthy young individuals. This pilot study has the potential to elucidate the specific mechanisms through which these DRD2 variants operate in modulating the function of the nigrostriatal dopaminergic system. The findings from this pilot study will set a critical foundation for near-future studies using PHNO to better understand the pathophysiology of PD patients.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Valli, Mikaeel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~